We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO.
我们正在追踪 Ipsen 的市场扩张
最近 90 天内有 32 个信号。
Ipsen 的国际扩张与竞争对手的对比情况
Ipsen你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Ipsen你 | 0 | 0 | — | 0 | 0 |
Microbiologist – Ipsen Wrexham
查看职位Wrexham, Wales, United Kingdom · 2周前
National Corporate Accounts Director
查看职位New York, NY · 上周
Vice President, Head of External Innovation China, Strategy & Operations
查看职位Cambridge, MA · 上周
Glasses on. Meetings moved outside. Coffee on the terrasse. This is what spring at Ipsen HQ looks like. ☀️Same mission. Much better backdrop. ...
已结束Paris 🇫🇷 London 🇬🇧 Cambridge 🇺🇸Different views outside the windows, but the same spirit inside: we share ideas, move fast, and focus on what matters most—people and patients.Same mission. Just a few time zones apart. ...
已结束
Download the 2025 Integrated Annual Report
已结束益普生报告2025年第一季度销售额以固定汇率计算增长11.6%，由三个治疗领域推动。公司确认2025年全年财务指引并强调研发管线进展。
Ipsen报告Onivyde在胰腺癌治疗中的三期试验取得积极结果，显示转移性胰腺腺癌长期存活患者的中位总生存期为19.5个月。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Ipsen 的业务、市场和增长信号的快速解答。
